| Characteristic |
Number of patients (per cent) |
Number of Deaths (per cent) |
| Gender |
Male |
418(44.9) |
179(42.82) |
| Female |
512(55.1) |
187(36.52) |
| Age (Year) |
15-24 |
94(10.1) |
35(37.23) |
| 25-34 |
375(40.3) |
142(37.87) |
| 35-44 |
304(32.7) |
121(39.8) |
| 45+ |
157(16.9) |
68(43.31) |
| WHO clinical stage |
Stage I and II |
116(12.5) |
34(29.31) |
| Stage III |
699(75.2) |
261(37.34) |
| Stage IV |
115(12.4) |
71(61.74 |
| Regimen |
Stavudine |
348(37.4) |
132(37.93) |
| Zidovudine |
516(55.5) |
225(43.6) |
| Marital status |
Unmarried |
118(12.7) |
48(40.68) |
| Married |
387(41.6) |
145(37.47) |
| Separated |
425(45.7) |
173(40.71) |
| Education* |
Illiterate |
290(31.7) |
106(36.55) |
| Primary |
309(33.2) |
129(41.75) |
| Secondary+ |
322(34.6) |
128(39.75) |
| Occupation * |
Employed |
206(22.2) |
77(37.38) |
| Unemployed |
606(65.2) |
250(41.25) |
| Residence* |
Urban |
673(72.4) |
257(38.19) |
| Rural |
242(26.0) |
102(42.15) |
| CTX prophylaxis* |
Yes |
554(59.6) |
194(35.02 |
| No |
278(29.9) |
133(47.84 |
| Adherence * |
Good |
648(69.7) |
168(25.93 |
| Poor |
191(20.5) |
131(68.59 |
| Baseline functional status |
Working |
538(57.8) |
154(28.62 |
| Ambulatory |
324(34.8) |
164(50.62 |
| Bedridden |
68(7.3) |
48(70.59 |
| Anemia * |
No |
430(46.2) |
84(19.53 |
| Mild |
259(27.8) |
116(44.79 |
| Mod to Severe |
144(15.5) |
102(70.83 |
| CD4 count (cells/ml) |
≥200 |
95(10.2) |
20(21.05 |
| 100-199 |
428(46.0) |
132(30.84 |
| 50-99 |
212(22.8) |
96(45.28) |
| <50 |
195(21.0) |
118(60.51) |
|
